You are being forwarded to your requested URL of https://www.lowenstein.com/news-insights/publications/client-alerts/congress-reauthorizes-pediatric-priority-review-voucher-program-in-fy2026-budget-renewed-incentives-for-rare-pediatric-drug-development-fdalife-sciences?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=